0001209191-23-002593.txt : 20230109 0001209191-23-002593.hdr.sgml : 20230109 20230109171348 ACCESSION NUMBER: 0001209191-23-002593 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230105 FILED AS OF DATE: 20230109 DATE AS OF CHANGE: 20230109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kornitzer Benjamin CENTRAL INDEX KEY: 0001855842 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40332 FILM NUMBER: 23518874 MAIL ADDRESS: STREET 1: C/O AGILON HEALTH, INC. STREET 2: 6210 E HWY 290, SUITE 450 CITY: AUSTIN STATE: TX ZIP: 78723 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: agilon health, inc. CENTRAL INDEX KEY: 0001831097 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 371915147 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6210 E HWY 290 STREET 2: SUITE 450 CITY: AUSTIN STATE: TX ZIP: 78723 BUSINESS PHONE: 562-256-3800 MAIL ADDRESS: STREET 1: 6210 E HWY 290 STREET 2: SUITE 450 CITY: AUSTIN STATE: TX ZIP: 78723 FORMER COMPANY: FORMER CONFORMED NAME: Agilon Health Topco, Inc. DATE OF NAME CHANGE: 20201103 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-01-05 0 0001831097 agilon health, inc. AGL 0001855842 Kornitzer Benjamin C/O AGILON HEALTH, INC. 6210 E HWY 290, SUITE 450 AUSTIN TX 78723 0 1 0 0 Chief Med. & Quality Officer Common Stock 2023-01-05 4 M 0 2698 8.99 A 13124 D Common Stock 2023-01-05 4 S 0 2698 15.5098 D 10426 D Common Stock 2023-01-06 4 M 0 2698 8.99 A 13124 D Common Stock 2023-01-06 4 S 0 2698 15.4565 D 10426 D Options (Rights to Buy) 8.99 2023-01-05 4 M 0 2698 0.00 D 2030-01-31 Common Stock 2698 246415 D Options (Rights to Buy) 8.99 2023-01-06 4 M 0 2698 0.00 D 2030-01-31 Common Stock 2698 243717 D Includes restricted stock units. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $15.44 to $15.61, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $15.40 to $15.61, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. These options were granted on January 31, 2020 and vested on September 14, 2021. /s/ Timothy Bensley, as Attorney-in-Fact 2023-01-09